Neuroblastoma is one of the most common childhood tumours, and in its high-risk form is one of the most difficult childhood cancers to cure, despite intensive therapy. This important project is researching a new immunotherapy approach to develop more effective and less toxic treatments to give more children a chance of survival.
New approaches to treating high-risk neuroblastoma in children are desperately needed, as current treatments are highly toxic and not always effective. With this work Professor John and his team have a real chance of developing an effective immunotherapy approach.
* this project is being funded in collaboration with Great Ormond Street Hospital Children’s Charity, with each charity contributing 50 per cent of the total cost of £302,390.
